BMP Sunstone Sees Larger Market Share From China Healthcare Reforms, PE Buy Out In The Works?

SHANGHAI - U.S.-listed Chinese pharmaceutical manufacturer and distributor BMP Sunstone reported a 25.8 percent increase in revenue in the second quarter compared to the same year-ago period, for $40.9 million in revenue. The company anticipates gaining market share from China's ongoing healthcare reforms, for which the Chinese government has pledged to invest $124 billion from 2009 to 2011